UCB to acquire Candid Therapeutics for up to $2.2 billion Business May 3, 2026adminLeave a Comment on UCB to acquire Candid Therapeutics for up to $2.2 billion Advertisements UCB to acquire Candid Therapeutics for up to $2.2 billion Advertisements